| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/14/2010 | WO2009111625A3 Peptide inhibition of lung epithelial apoptosis and pulmonary fibrosis |
| 01/14/2010 | WO2009108621A3 Methods and compositions for modulating insulin regulation |
| 01/14/2010 | WO2009099642A3 Proteomic analysis of active multiple sclerosis lesions |
| 01/14/2010 | WO2009083188A3 Compositions and methods for prophylaxis and treatment of cellular degenerative disorders |
| 01/14/2010 | WO2009083185A3 Compositions and methods for prophylaxis and treatment of cellular degenerative ophthalmic disorders |
| 01/14/2010 | WO2009076173A3 Fluorinated tripeptide hcv serine protease inhibitors |
| 01/14/2010 | WO2009037586A3 Use of peptidic vasopressin receptor agonists |
| 01/14/2010 | WO2009034453A3 Method for the immobilization of bioactive molecules within a polymeric substrate resistant to the stomach acids as oral drug delivery system |
| 01/14/2010 | WO2008150821A8 Modified nucleotide sequence encoding glucagon-like peptide-1 (glp-1) |
| 01/14/2010 | WO2008106662A3 Nitrilases, nucleic acids encoding them and methods for making and using them |
| 01/14/2010 | WO2006014505A9 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 01/14/2010 | WO2003064603A9 Nucleic acid molecule encoding iwu-1 |
| 01/14/2010 | WO2003012125A9 Mre11: modulation of cellular proliferation |
| 01/14/2010 | WO2002072609A9 Neuroactive peptides for prevention and/or treatment of hypoxia and neuropathic pain |
| 01/14/2010 | US20100010470 Nanotube-Reinforced Balloons For Delivering Therapeutic Agents Within Or Beyond The Wall of Blood Vessels, And Methods Of Making And Using Same |
| 01/14/2010 | US20100010207 Rna interference mediating small rna molecules |
| 01/14/2010 | US20100010202 Human antibodies derived from immunized xenomice |
| 01/14/2010 | US20100010201 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods |
| 01/14/2010 | US20100010200 for Systemic Inflammatory Response Syndrome (SIRS), including severe sepsis, septic shock and sepsis related to cardiac dysfunction |
| 01/14/2010 | US20100010195 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
| 01/14/2010 | US20100010075 COMPOUNDS FOR ELICITING OR ENHANCING IMMUNE REACTIVITY TO HER-2/neu PROTEIN FOR PREVENTION OR TREATMENT OF MALIGNANCIES IN WHICH THE HER-2/neu ONCOGENE IS ASSOCIATED |
| 01/14/2010 | US20100009965 Cyclic malonamides as inhibitors of abeta protein production |
| 01/14/2010 | US20100009924 Compositions and methods for improving cardiovascular function |
| 01/14/2010 | US20100009923 Antigens Targeted by Pathogenic Al4 T Cells in Type 1 Diabetes and Uses Thereof |
| 01/14/2010 | US20100009922 Hypotensive peptides from soy proteins and method of preparation |
| 01/14/2010 | US20100009921 Pharmaceutical compositions and methods for peptide treatment |
| 01/14/2010 | US20100009920 Ttk as tumor marker and therapeutic target for lung cancer |
| 01/14/2010 | US20100009919 Apolipoprotein A1 Mimetics and Uses Thereof |
| 01/14/2010 | US20100009918 Method for the administration of ligands, agonists of ligands of the tnf family with reduced toxicity |
| 01/14/2010 | US20100009917 Modulating Enzymatic Processes by Addition of Diolcontaining Substances |
| 01/14/2010 | US20100009916 Selective vpac2 receptor peptide agonists |
| 01/14/2010 | US20100009915 Compositions comprising fungal immunomodulatory protein and use thereof |
| 01/14/2010 | US20100009914 Method of protecting sensitive molecules from a photo-polymerizing environment |
| 01/14/2010 | US20100009913 Uses for Yerba Santa |
| 01/14/2010 | US20100009911 Osteogenic synergic composition |
| 01/14/2010 | US20100009910 Methods for administering long-lasting hypoglycemic agents |
| 01/14/2010 | US20100009909 Peptides binding the phosphatase 2a protein |
| 01/14/2010 | US20100009907 Glucagon-Like Peptides and Uses Thereof |
| 01/14/2010 | US20100009906 Anticancer Treatments |
| 01/14/2010 | US20100009905 Compositions and Methods for Detection, Prognosis and Treatment of Colon Cancer |
| 01/14/2010 | US20100009904 Modified Exedins and Uses Thereof |
| 01/14/2010 | US20100009903 Methods for Promoting Wound Healing and/or Reducing Scar Formation |
| 01/14/2010 | US20100009902 Glycoconjugation Using Saccharyl Fragments |
| 01/14/2010 | US20100009901 Mineral Amino Acid Polysaccharide Complex |
| 01/14/2010 | US20100009900 2-{3-[2-(2,3-Dihydro-benzofuran-5-yl)-ethyl]-1H-indol-4-yloxy} beta -D-glucopyranoside; sodium glucose transporter inhibitor; antidiabetic agent; Syndrome X, obesity, nephropathy, neuropathy, retinopathy, atherosclerosis, hypertension, ischemia, stroke, heart disease, irritable bowel disorder, cataracts |
| 01/14/2010 | US20100009899 Novel Insulin Derivatives |
| 01/14/2010 | US20100009898 Protease resistant insulin analogues |
| 01/14/2010 | US20100009896 Capture agents and related compositions, methods and systems |
| 01/14/2010 | US20100009895 Method for selective localization of active agents at and in mitochondria and corresponding active agents |
| 01/14/2010 | US20100009438 Dendritic cell potentiation |
| 01/14/2010 | US20100009437 Isolated proteins MAGE-4 and MAGE-41 |
| 01/14/2010 | US20100009425 Glycoprotein synthesis |
| 01/14/2010 | US20100009410 Methods and Constructs for Expressing Polypeptide Multimers in Eukaryotic Cells Using Alternative Splicing |
| 01/14/2010 | US20100009384 Acyltransferase -1 (ACTR-1); for identifying modulators or are useful themselves as compositions for diagnosis and treatment of disease or disorder that arise from malfunction of the regulation of triacylglycerol (triglyceride) and phospholipid biosynthesis e.g. atherosclerosis; cardiovascular disorders |
| 01/14/2010 | US20100009366 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 01/14/2010 | US20100009345 Compositions and methods comprising a ligand of chemerin R |
| 01/14/2010 | US20100009014 Use of composition for manufacture of medicant and method for inhibiting formation of body fat |
| 01/14/2010 | US20100008996 Inhalative and instillative use of semifluorinated alkanes as an active substance carrier in the intrapulmonary area |
| 01/14/2010 | US20100008994 Electrospun structures and methods for forming and using same |
| 01/14/2010 | US20100008979 Delivery of therapeutic agents to the bone |
| 01/14/2010 | US20100008973 Compositions And Methods For Wound Healing |
| 01/14/2010 | US20100008969 Biomaterial scaffolds with keratin for tissue engineering |
| 01/14/2010 | US20100008965 Biocompatible medical products having enhanced anti-thrombogenic properties |
| 01/14/2010 | US20100008964 Isolated stromal cells and methods of using the same |
| 01/14/2010 | US20100008943 Extracellular matrix-binding proteins from staphylococcus aureus |
| 01/14/2010 | US20100008941 vaccination directed against the hepatitis C virus (HCV); |
| 01/14/2010 | US20100008940 Peptide analogs capable of enhancing stimulation of a glioma-specific ctl response |
| 01/14/2010 | US20100008938 Self assembling amphiphilic polymers as antiviral agents |
| 01/14/2010 | US20100008937 Targeted delivery to leukocytes using non-protein carriers |
| 01/14/2010 | US20100008936 IL-16 antagonist peptides and DNA encoding the peptides |
| 01/14/2010 | US20100008932 Use of soluble cd160 to suppress immunity |
| 01/14/2010 | US20100008931 Coronin 1 Modulators for the Treatment of Autoimmune and Lymphoproliferative Disorders and Mycobacterial Infections |
| 01/14/2010 | US20100008927 Use of (S)-Roscovitine for Prevention and/or Treatment of Neurological Diseases |
| 01/14/2010 | US20100008926 Novel proteins and use thereof |
| 01/14/2010 | US20100008924 Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |
| 01/14/2010 | US20100008923 Organic Compounds |
| 01/14/2010 | US20100008921 Diagnostic and Therapeutic Target Adarb2 Proteins for Neurodegenerative Diseases |
| 01/14/2010 | US20100008919 Peptide facilitating the entry of a linked molecule into a mammalian cancer cell; Using copper binding protein as a delivery vehicle; used to inhibit angiogenesis that accompanies tumor development |
| 01/14/2010 | US20100008918 Methods for dosing an actriib antagonist and monitoring of treated patients |
| 01/14/2010 | US20100008916 Inhibit inflammation for long periods without accompanying serious side effects in the drug therapy to patients with inflammatory bowel syndrome |
| 01/14/2010 | US20100008913 Methods and compositions for treating platelet-related disorders |
| 01/14/2010 | US20100008912 Combination drug |
| 01/14/2010 | US20100008910 Methods and compositions for the diagnosis and treatment of cancer |
| 01/14/2010 | US20100008904 administering to the subject an effective amount of an inhibitor of an acid-sensing ion channel 3, wherein the inhibitor is a polypeptide that binds to the acid-sensing ion channel 3 |
| 01/14/2010 | US20100008903 Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment |
| 01/14/2010 | US20100008901 Methods for the treatment and prevention of cancer |
| 01/14/2010 | US20100008900 Annexin ii compositions for treating or monitoring inflammation or immune-mediated disorders |
| 01/14/2010 | US20100008899 Methods of diagnosis and treatment for metabolic disorders |
| 01/14/2010 | US20100008898 Chymotrypsin from lucilia sericata larvae and its use for the treatment of wounds |
| 01/14/2010 | US20100008897 Composition for providing a benefit to a keratin-containing substrate |
| 01/14/2010 | US20100008896 Use of Fenretinide or Bioactive Derivatives Thereof and Pharmaceutical Compositions Comprising the Same |
| 01/14/2010 | US20100008895 used in vaccines against A. salmonicida infections such as fish disease furunculosis; ADP-ribosylating toxins |
| 01/14/2010 | US20100008894 Process of Screening a Molecule as a Candidate Drug for the Treatment of Bipolar Disorder |
| 01/14/2010 | US20100008891 Production of Pluripotent Cells Through Inhibition of Bright/Arid3a Function |
| 01/14/2010 | US20100008888 Co-administration of cg250 and il-2 or ifn-alpha for treating cancer such as renal cell carcinomas |
| 01/14/2010 | US20100008858 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules |
| 01/14/2010 | US20100008855 Production and Use of Novel Peptide-Based Agents with Bispecific Antibodies |
| 01/14/2010 | US20100008853 Anti ganglioside gd3 antibodies and uses thereof |
| 01/14/2010 | CA2734348A1 Glycopeptide constructs and uses thereof |
| 01/14/2010 | CA2730420A1 Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use |